This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

Retinal Pioneers Programme

Bitesize OCT Knowledge Checkers

Test your OCT knowledge

Retinal Pioneers

Test your knowledge of optical coherence tomography (OCT) disease biomarkers in this series of OCT images and associated knowledge-checker questions provided by Professor Richard Gale, consultant ophthalmologist, York Teaching Hospitals NHS Foundation Trust. Can you identify all of the relevant biomarkers?

 

The knowledge checkers below have been developed for use on desktop computers.

HOW USEFUL IS OCT-A FOR DMO? (NEW!)

Prescribing information for EYLEA® (aflibercept) can be found here.

MANAGEMENT OF DMO

Prescribing information for EYLEA® (aflibercept) can be found here.

DIAGNOSIS OF DMO

Prescribing information for EYLEA® (aflibercept) can be found here.

DIFFERENTIAL DIAGNOSIS OF nAMD

Prescribing information for EYLEA® (aflibercept) can be found here.

USING OCT TO RECOGNISE GA IN AMD

Prescribing information for EYLEA® (aflibercept) can be found here.

IDENTIFYING DISEASE BIOMARKERS: HOW RELEVANT IS OCT-A?

Prescribing information for EYLEA® (aflibercept) can be found here.

OCT BIOMARKERS OF DISEASE ACTIVITY IN nAMD

Prescribing information for EYLEA® (aflibercept) can be found here.

EYLEA® (aflibercept) 8 mg
Discover data and resources about EYLEA 8 mg
PP-EYL-GB-2321, September 2024
Retinal Pioneers Programme
A source of on-demand, educational resources developed in collaboration with national and international thought leaders
EYLEA® (aflibercept) 2 mg
Discover data and resources about EYLEA 2 mg

PP-EYL-GB-2743 | February 2025